Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pedro Jesús Gómez Arias
288  Ergebnisse:
Personensuche X
?
1

¡Siempre en el mismo sitio, doctora!:

Maria del Carmen Arias Blanco ; Juana Redondo Sánchez ; Pedro Jesús Gómez Arias
http://www.sciencedirect.com/science/article/pii/S260507302030016X.  , 2020
Link: https://doi.org/10.1016/..
 
?
2

Bullous erythema elevatum diutinum associated with immunogl..:

Pedro Jesus Gomez Arias ; José Luis Hernández Romero ; Juan Luis Sanz Cabanillas..
http://www.e-ijd.org/article.asp?issn=0019-5154;year=2020;volume=65;issue=2;spage=164;epage=165;aulast=Gomez.  , 2020
Link: https://doi.org/10.4103/..
 
?
3

Doppelter subkutan gestielter Insellappen zur Rekonstruktio..:

Salido‐Vallejo, Rafael ; Antoñanzas, Javier ; Gómez Arias, Pedro Jesús.
JDDG: Journal der Deutschen Dermatologischen Gesellschaft.  22 (2024)  5 - p. 727-729 , 2024
Link: https://doi.org/10.1111/..
 
?
4

Double subcutaneous island pedicle flap for reconstruction ..:

Salido‐Vallejo, Rafael ; Antoñanzas, Javier ; Gómez Arias, Pedro Jesús.
JDDG: Journal der Deutschen Dermatologischen Gesellschaft.  22 (2024)  5 - p. 727-729 , 2024
Link: https://doi.org/10.1111/..
 
?
5

Teledermatology in a rural area of southern Spain: A 12‐yea..:

Gómez Arias, Pedro Jesús ; Arias Blanco, María del Carmen ; Escribano Villanueva, Francisco..
Australasian Journal of Dermatology.  62 (2021)  3 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
6

Efficacy and Safety of Janus Kinase Inhibitors in Type I In..:

Adis Journals on behalf of (10318149) ; Pedro Jesús Gómez Arias (10324680) ; Francisco Gómez-García (4724718)...
https://figshare.com/articles/media/Efficacy_and_Safety_of_Janus_Kinase_Inhibitors_in_Type_I_Interferon-Mediated_Monogenic_Autoinflammatory_Disorders_A_Scoping_Review/14237444.  , 2021
Link: https://doi.org/10.6084/..
 
?
7

¡Siempre en el mismo sitio, doctora!:

Arias Blanco, Maria del Carmen ; Redondo Sánchez, Juana ; Gómez Arias, Pedro Jesús
Atención Primaria Práctica.  2 (2020)  4-5 - p. 100054 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Efficacy and safety of anakinra and canakinumab in PSTPIP1-..:

Sanz-Cabanillas, Juan Luis ; Gómez-García, Francisco ; Gómez-Arias, Pedro Jesús...
Frontiers in Immunology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
9

A Scoping Review on Use of Drugs Targeting the JAK/STAT Pat..:

Gómez-García, Francisco ; Gómez-Arias, Pedro Jesús ; Montilla-López, Ana...
Frontiers in Medicine.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
10

Efficacy and Safety of Janus Kinase Inhibitors in Type I In..:

Gómez-Arias, Pedro Jesús ; Gómez-García, Francisco ; Hernández-Parada, Jorge...
Dermatology and Therapy.  11 (2021)  3 - p. 733-750 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Drugs targeting the JAK/STAT pathway for the treatment of i..:

Gómez-García, Francisco ; Gómez-Arias, Pedro Jesús ; Hernandez, Jorge...
BMJ Open.  9 (2019)  5 - p. e028303 , 2019
Link: https://doi.org/10.1136/..
 
?
12

Evolution of international collaborative research efforts t..:

Viguera-Guerra, Isabel ; Ruano, Juan ; Aguilar-Luque, Macarena...
PLOS ONE.  14 (2019)  2 - p. e0211919 , 2019
Link: https://doi.org/10.1371/..
 
?
13

Efficacy and safety of anakinra and canakinumab in PSTPIP1-..:

Juan Luis Sanz-Cabanillas ; Francisco Gómez-García ; Pedro Jesús Gómez-Arias...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1339337/full.  , 2024
Link: https://doi.org/10.3389/..
 
?
14

DataSheet_1_Efficacy and safety of anakinra and canakinumab..:

Juan Luis Sanz-Cabanillas ; Francisco Gómez-García ; Pedro Jesús Gómez-Arias...
doi:10.3389/fimmu.2023.1339337.s001.  , 2024
Link: https://doi.org/10.3389/..
 
?
15

DataSheet_1_Efficacy and safety of anakinra and canakinumab..:

Juan Luis Sanz-Cabanillas ; Francisco Gómez-García ; Pedro Jesús Gómez-Arias...
doi:10.3389/fimmu.2023.1339337.s001.  , 2024
Link: https://doi.org/10.3389/..
 
1-15